Tag: acute stroke

Wallaby Medical stroke treatment

Wallaby Medical raises funds to accelerate device development for stroke treatment

Wallaby Medical announced it has recently closed a series B+ financing round worth more than US$20 million. The company focuses on developing and commercialising...
stroke trials SNIS 2020

LIVE from SNIS: The stroke trials you need to know about

From acute interventions to endovascular therapy indication expansion, Sunil Sheth from McGovern Medical School at UTHealth, Houston, USA, kick-started the Society of NeuroInterventional Surgery’s...
THALES trial results

Brilinta significantly reduced the rate of the composite of stroke and...

Results from the positive phase III THALES trial showed AstraZeneca’s Brilinta (ticagrelor) 90mg used twice daily and taken with daily aspirin for 30 days,...
covid causes disruption to clinical trials

COVID-19 causes “widespread disruption” to neuroendovascular research around the globe

“Widespread disruption of neuroendovascular trials occurred because of COVID-19,” conclude the investigators of a survey-based study examining the impact of the pandemic. Now, as...
COVID-19

Stroke risk higher in patients with COVID-19 than influenza

A higher rate of stroke has been reported in adults with COVID-19 compared to a cohort of patients with influenza. A retrospective study published...
stroke amid COVID-19

“Stoicism kills”: A concerning trend is causing preventable stroke deaths

A concerning new trend has been revealed by the Stroke Association. The charity states that the most at-risk groups are least likely to call...
COVID-19 stroke

Incidence of stroke due to COVID-19 lower than previously reported, study...

A recently published study has shown fewer people than previously reported have had strokes as a result of COVID-19; however, strokes that accompany the...
BASICS study basilar artery occlusion

Endovascular therapy fails to outperform best medical management in basilar artery...

Final results of the Basilar artery international cooperation study (BASICS) have been reported by Wouter J Schonewille (University Medical Centre Utrecht, Utrecht, the Netherlands)...
EFFECTS trial fluoxetine

Routine use of fluoxetine after acute stroke not recommended

The final results of EFFECTS (Efficacy of fluoxetine: A randomised controlled trial in stroke) have been presented by Erik Lundström (Uppsala University, Uppsala, Sweden)...
DIRECT-MT

Direct mechanical thrombectomy alone deemed non-inferior to its combination with alteplase

Investigators of the DIRECT-MT trial, who evaluated Chinese patients with acute ischaemic stroke from large-vessel occlusion, concluded that endovascular thrombectomy alone was non-inferior in...
COVID-19 stroke new york

COVID-19 patients are “hypercoagulable and at an increased risk for stroke”

The association between COVID-19 and the increased incidence of stroke continues to grow. Situated within the pandemic’s epicentre, Kurt Yaeger and J Mocco, neurosurgeons...
telemedicine COVID-19

Telemedicine in neurointervention set to last beyond the hype

“Telehealth is finally upon us. As someone who has been practicing in this world for several years, I was always waiting for an inflection...

EXTEND-IA TNK Part 2 trial finds no benefit of higher tenecteplase...

With the original trial demonstrating a higher incidence of substantial reperfusion with tenecteplase compared with alteplase prior to endovascular therapy, EXTEND-IA TNK Part 2...
COVID-19 in London

Stroke care in London as pressure on NHS rises amid COVID-19

Following the announcement that the UK will remain on lockdown for the foreseeable future, NeuroNews speaks to Shahram Derakhshani about the impact of COVID-19...
Demetrius Lopes

The role of neurosurgeons during COVID-19

COVID-19 represents a global challenge that has exposed the USA’s fragmented public healthcare system, writes Demetrius Lopes. Here, he details Chicago’s action plan in...
SNIS recommendations COVID-19

SNIS releases recommendations for emergent neurointerventional patients during COVID-19

The Society of NeuroInterventional Surgery (SNIS) has published a set of recommendations for the care of emergent neurointerventional patients during the COVID-19 pandemic. “Acute...
Endovascular cooling Ron Solar

Selective endovascular cooling with TwinFlo catheter shows promise for neuroprotection in...

Ron Solar (ThermopeutiX, San Diego, USA) and colleagues report in EuroIntervention that the TwinFlo catheter (ThermopeutiX), in pigs, was associated with rapid, selective, deep...
diffusion pharmaceuticals

Diffusion Pharmaceuticals anticipates coronavirus will slow enrolment in its ambulance-based stroke...

Diffusion Pharmaceuticals has announced that it expect delays in enrolment in the company’s ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to...

ISC News: Blacks, Hispanics of Caribbean descent have higher stroke risk...

Both Blacks and Hispanics of Caribbean descent living in Northern Manhattan have a significantly higher risk of stroke than their non-Hispanic, white neighbours, according...
portable MRI

Portable MRIs bring diagnostics to stroke patients’ bedside

A portable, low-field magnetic resonance imaging (MRI) system may become a safe and practical way to get accurate brain images at a patient’s bedside,...

Quick and easy imaging interpretation for stroke therapy: The promise of...

Stroke treatment is time-sensitive. Every minute counts. Every delay in decision-making affects patient outcome. Given this, JM Ospel and colleagues from the University of...
blood pressure reduction

Blood pressure reduction inversely associated with poor outcome after successful reperfusion

A study investigating the relationship between systolic blood pressure (BP) reduction and outcome of mechanical thrombectomy has shown that systolic BP, in the first...
FRED microvention device

MicroVention’s FRED flow diverter now FDA approved

MicroVention, a US based subsidiary of Terumo and a global neurovascular company announced the US FDA premarket approval (PMA) for the FRED (Flow re-direction...
imperative care financing series C

Imperative Care announces US$85 million Series C financing for stroke treatments

Imperative Care has completed the initial closing of a Series C financing of US$85 million to support the commercial launch of the company’s portfolio,...
artificial intelligence

Viz.ai launches a range of new AI features

Viz.ai has announced a number of new features at the Society of Vascular and Interventional Neurology (SVIN) annual meeting in Atlanta, USA (20–23 November,...
brainomix

Brainomix AI software improves stroke treatment rates at Budapest University Hospital

On the 8th of November 2019, during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Hungary, Bence Gunda...
aidoc AI stroke treatment

Aidoc releases complete AI package to speed identification and treatment of...

Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...

Advanced engineering improves rates of revascularisation through the first-pass effect

Advertorial In acute ischaemic stroke, fast and complete recanalisation of the occluded vessel is associated with improved outcomes. While morbidity and mortality in these patients...
burnout stroke

The burden of a stroke call: 56% of US neurointerventionalists meet...

Fifty-six per cent of US neurointerventionalists meet criteria for burnout. This statistic, presented by Kyle Fargen from Wake Forest Baptist Health in Winston-Salem (USA)...
Physicians Educational Resource

Physicians’ Education Resource releases agenda for the 1st Annual International Congress...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), announces the full agenda for the 1st Annual International Congress on...
EEG brain

Neurotechnology holds promise for chronic stroke patients

Personalised neurotechnology-aided rehabilitation of the arm could improve recovery in severe chronic stroke patients according to a new paper published in the journal Brain. Neurotechnology-based...

Canon Medical receives FDA clearance for deep convolutional neural network image...

Building on its advanced image reconstruction technologies, Canon Medical Systems USA has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
RAPID imaging

RAPID imaging platform expands options for speedy stroke treatment at Atlantic...

Recognising how vital it is that stroke neurosurgeons and neurologists receive timely information about the type of stroke a person is having so they...
Alteplase

Alteplase at 0.6mg/kg for stroke with unknown time of onset is...

Although an acceptable safety profile was demonstrated for MRI-guided thrombolysis with alteplase at 0.6mg/kg for stroke with unknown time of onset, the latter approach...

Interdisciplinary approach to in-hospital stroke improves detection and treatment time

A recent study found that revision of an existing in-hospital stroke (IHS) protocol was associated with a lower rate of stroke mimics, and shorter...

Intensive blood pressure lowering beyond recommendations safely reduced the risk of...

Although intensive blood pressure lowering with intravenous thrombolysis is safe in patients with acute ischaemic stroke, the observed reduction in intracranial haemorrhage did not...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...

Artificial Intelligence in prehospital stroke detection: Automation in motion

Acknowledging the current limitations that hinder optimal stroke screening in the prehospital setting, Mark McDonald (University of Virginia, Charlottesville, USA), one of the co-founders...

Presented at the ISC: PHAST-TSC trial for treatment of acute stroke

Following the American Heart Association’s International Stroke Conference (ISC; 5–8 February, Hawaii, USA), Diffusion Pharmaceuticals announce a poster presented at the conference, outlining the...

Perflow Medical expands IP coverage for Stream and Cascade devices

Perflow Medical has announced the issuance of four international patents that expand the global intellectual property (IP) coverage for the novel Stream Dynamic Neuro-Thrombectomy...

RACECAT trial comparing transfer of acute stroke patients enrols 715 patients

The preliminary results of the RACECAT trial—a study comparing transfer of acute stroke patients with suspected large vessel occlusion (LVO) to the closest local...

Innovative on-ambulance PHAST-TSC trial for treatment of acute stroke approved by...

Diffusion Pharmaceuticals, a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where...